Media CoverageJune 6, 2024ASCO24: BillionToOne unveils results from tumour profiling test comparisonRead
Media CoverageMay 3, 2024GenomeWeb- BillionToOne Pushing Forward in Cancer Diagnostics With First Data on Response Monitoring TestRead
Media CoverageMay 3, 2024BioWorld MedTech Interview- BillionToOne test reduces need for Rhogam in 40% of Rh-negative pregnanciesRead
Press ReleasesApril 17, 2024BILLIONTOONE MITIGATING RHOGAM(R) SHORTAGE WITH UNITY FETAL RhD™ NON-INVASIVE PRENATAL TESTRead
Media CoverageMarch 19, 2024BillionToOne is recognized by Forbes as one of America’s Best Startup Employers for 2024!Read